Skip to content

Effectiveness of dry needling in perceived pain, quality of gait and spasticity in patients with multiple sclerosis

Effectiveness of dry needling in perceived pain, quality of gait and spasticity in patients with multiple sclerosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000880145
Acronym
DNMS
Enrollment
25
Registered
2019-06-20
Start date
2019-07-01
Completion date
Unknown
Last updated
2020-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Given the high prevalence of spasticity in Multiple Sclerosis and the functional limitations it causes in terms of pain and alteration of walking parameters, our study aims to give a non-pharmacological solution, through Physiotherapy to this problem. In particular, an intervention of Dry Puncture (PS) in two muscles (Recto Femoral and Medial Gastrocnemius), comparing the results with the obtained with the intervention of PS placebo in terms of perceived pain (algometry), walking functionality (symmetry in spatio-temporal parameters and increase in the average speed of the march) and improvement of patterns electromyography, in a population of patients with MS.

Interventions

The intervention consists of Dry Needling (DN) using disposable stainless steel needles of 0.3 mm × 50 mm or 0.3 mm x 40 mm (Agupunt, Barcelona, Spain), depending on the depth of the muscle to be treated. The type of DN that will be used will be the technique of fast entry and exit of the needle in the Myofascial Trigger Point of the Rectus Femoris and Gastrocnemius Medialis muscles, according to a series of published diagnostic criteria (criteria of McDonald, 2010) and application guidelines [1

The intervention consists of Dry Needling (DN) using disposable stainless steel needles of 0.3 mm × 50 mm or 0.3 mm x 40 mm (Agupunt, Barcelona, Spain), depending on the depth of the muscle to be treated. The type of DN that will be used will be the technique of fast entry and exit of the needle in the Myofascial Trigger Point of the Rectus Femoris and Gastrocnemius Medialis muscles, according to a series of published diagnostic criteria (criteria of McDonald, 2010) and application guidelines [1], until a minimum of 3-4 local twitch responses, always taking into account the tolerance of the patient, who will be warned that in any part of the process ,can be directed to the physiotherapist to request stop. The intervention will be performed in the lower limb most affected by spasticity (which presents a higher Ashworth score in the target muscles). A puncture will be made in each muscle per session, 1 session per week, for 2 weeks. The intervention will be performed in a hospital environment. The duration of each dry needling session will be approximately 45-60 seconds for muscle, until the local twitch responses disappeared or until the patient could no longer bear the pain. 1. Tang L, Li Y, Huang Q-M, Yang Y. Dry needling at myofascial trigger points mitigates chronic post-stroke shoulder spasticity. [Internet]. Vol. 13, Neural regeneration research. 2018. p. 673-6.

Sponsors

University of Cadiz
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Patients with a diagnosis of Multiple Sclerosis, according to the criteria of McDonald 2010. Patients older than 18 years. Patients who can walk (with or without support), with an EDSS score of 0-6.5. Patients with stability of the disease, defined as absence of outbreaks in the previous month. Patients who have signed the informed consent, show voluntariness to participate and can complete the scales and the protocol.

Exclusion criteria

Pregnant patients Patients with comorbidity or decompensated disease in the last month. Patients who have received corticosteroid treatment in the last month. Patients unable to adequately meet the requirements of the study for any reason, condition or cause, at the discretion of the researcher. Patients who present some physical impediment to perform the walk test. Patients who have had infiltrations with botulinum toxin in the lower limb in the last 3 months.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 16, 2026